Transdermal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Transdermal Drug Delivery Pipeline Market Report Overview

Transdermal drug delivery devices are medicated adhesive patches placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. The transdermal drug delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

KKey Territories ·       The United States

·       Europe

·       Japan

·       India

·       Israel

KKey Categories ·       Active Formulations

·       Passive Formulations

KKey Regulatory Paths ·       CE

·       510(k)

·       MDITAC

·       Ninsho

·       ICAC

LLeading Companies ·       3P Biotechnologies Inc

·       AbbVie Inc

·       Abionic SA

·       Actuated Medical Inc

·       AcusMu Medtech Co Ltd

EEnquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Transdermal Drug Delivery Pipeline Market Segmentation by Categories

The key categories in the transdermal drug delivery pipeline market are active formulations and passive formulations. As of December 2024, active formulations have the highest number of pipeline products.

Transdermal Drug Delivery Pipeline Market Analysis by Categories, 2024 (%)

Transdermal Drug Delivery Pipeline Market Analysis by Categories, 2024 (%) 

Buy the Full Report for More Category Insights into the Transdermal Drug Delivery Pipeline Market

Download a Free Report Sample

Transdermal Drug Delivery Pipeline Market Segmentation by Territories

A few of the key territories associated with the transdermal drug delivery pipeline market are the United States, Europe, Japan, India, and Israel among others. As of December 2024, the US has the highest number of transdermal drug delivery pipeline products.

Transdermal Drug Delivery Pipeline Market Analysis by Territories, 2024 (%)

Transdermal Drug Delivery Pipeline Market Analysis by Territories, 2024 (%) 

Buy the Full Report for More Territory Insights into the Transdermal Drug Delivery Pipeline Market

Download a Free Report Sample

Transdermal Drug Delivery Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the transdermal drug delivery pipeline products market are CE, 510(k), MDITAC, Ninsho, and ICAC among others. As of December 2024, CE was the most followed pathway for pipeline products in the transdermal drug delivery market.

Transdermal Drug Delivery Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Transdermal Drug Delivery Pipeline Market Analysis by Regulatory Paths, 2024 (%) 

Buy the Full Report for More Regulatory Path Insights into the Transdermal Drug Delivery Pipeline Market

Download a Free Report Sample

Transdermal Drug Delivery Pipeline Market – Competitive Landscape

A few of the key companies associated with the transdermal drug delivery pipeline market are 3P Biotechnologies Inc, AbbVie Inc, Abionic SA, Actuated Medical Inc, and AcusMu Medtech Co Ltd among others.

3P Biotechnologies Inc: 3P Biotechnologies Inc. is developing medical devices, plant products, and therapeutics for treating cancer and chronic diseases. The company is headquartered in Prospect, Kentucky, the US.

AbbVie Inc (AbbVie): AbbVie Inc (AbbVie) is a specialty biopharmaceutical company, which discovers, develops, manufactures, and commercializes drugs for the treatment of chronic and complex diseases. Its drugs are indicated for the treatment of metabolic and rheumatological diseases, neurological disorders, skin diseases, rheumatoid arthritis, pain related to endometriosis, pediatric Crohn’s disease, cancer, and other serious health conditions.

Transdermal Drug Delivery Pipeline Market Analysis by Companies, 2024
Transdermal Drug Delivery Pipeline Market Analysis by Companies, 2024 Buy the Full Report for More Company Insights into the Transdermal Drug Delivery Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Transdermal Drug Delivery Pipeline Market Territories Outlook (2024)

  • Europe
  • The United States
  • India
  • Japan
  • Israel

Transdermal Drug Delivery Pipeline Market Regulatory Paths Outlook (2024)

  • CE
  • 510(k)
  • MDITAC
  • Ninsho
  • ICAC

Transdermal Drug Delivery Pipeline Market Categories Outlook (2024)

  • Active Formulations
  • Passive Formulations

Scope

This report provides:

  • Extensive coverage of the Transdermal Drug Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Transdermal Drug Delivery under development.
  • Develop market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3P Biotechnologies Inc
AbbVie Inc
Abionic SA
Actuated Medical Inc
AcusMu Medtech Co Ltd
Adynxx Inc
Aequus Pharmaceuticals Inc
AerMedX Ltd
Agile Therapeutics Inc
American Chemical Society
AMW GmbH
Amzell BV
Anodyne Nanotech Inc
Apogee Technology Inc
Asahi Kasei Pharma Corp
ASCIL Biopharm
Avecho Biotechnology Ltd
Avro Life Sciences
Better Life Pharmaceuticals Inc
BioNxt Solutions Inc
Boryung Pharmaceutical Co Ltd
Burke Pharmaceuticals LLC
Candesant Biomedical Inc
Carnegie Mellon University
Cassava Sciences Inc
CB Scientific Inc
Celltrion Inc
Cerimon Pharmaceuticals, Inc. (Inactive)
Changchun University of Chinese Medicine
Chrono Therapeutics Inc
Cipla Ltd
Clexio Biosciences Ltd
Corium LLC
CS Medica A/S
Daewon Pharmaceutical Co Ltd
Daewoong Pharmaceutical Co Ltd
DBV Technologies SA
DD Therapeutics LLC (Inactive)
Delpor Inc
Dermisonics Inc
Dharma Therapeutics, Inc. (Inactive)
Dong-A ST Co Ltd
Drexel University
DURECT Corp
Echo Therapeutics Inc (Inactive)
Emplicure AB
Endo International Plc
Endomimetics LLC
Extend Biosciences Inc
Fe3 Medical Inc
Feplen Health Research Pvt Ltd
Futura Medical Plc
Georgetown University
Georgia Institute of Technology
Georgia State University
Gerresheimer AG
GlobeStar Therapeutics Corp
Gylden Pharma Limited
Henley Ion LLC
Hera Health Solutions
Hisamitsu Pharmaceutical Co Inc
I.M. Sechenov First Moscow State Medical University
Icure Pharmaceutical Inc
ImmunoMatrix LLC
ImmuPatch
Indian Institute of Science
Indian Institute of Technology Bombay
Indian Institute of Technology Hyderabad
Indian Institute of Technology, Kanpur
InMed Pharmaceuticals Inc
Institute of Materials Research & Engineering
InteguRx Therapeutics LLC
Intercell AG (Inactive)
Interstitial NS
Isis Biopolymer Inc (Inactive)
James J. Peters VA Medical Center
Janisys
Jiaxing Xinwen Biotechnology Co Ltd
Karolinska Institute
Kindeva Drug Delivery LP
KTH Royal Institute of Technology
Leo Pharma AS
Libero Pharma Ltd
Livzon Pharmaceutical Group Inc
LTS Lohmann Therapie-Systeme AG
Luye Pharma Group Ltd
Massachusetts Institute of Technology
Mayne Pharma Group Ltd
Medherant Ltd
MEDRx Co Ltd
Microdermics Inc
Micron Biomedical Inc
Micropoint Technologies Pte Ltd
Mineed Technology Co Ltd
Mycrodose Therapeutics Inc
MyLife Technologies
Nanyang Technological University
National Dental Centre Singapore
National University of Singapore
nCap Medical LLC
Nemaura Pharma Ltd
NeuroDerm Ltd
Nexgel Inc
Nitto Denko Corp
North Carolina State University
Nova Graphene Ballistics Inc
Noven Pharmaceuticals Inc
NutriBand Inc
Nuvo Pharmaceuticals Inc (Inactive)
Ohio State University
Old Dominion University
Osprey Medical Inc
Pantec Biosolutions AG
PassPort Technologies Inc
PATH
Pebble Inc
PharmaTher Holdings Ltd
Privo Technologies Inc
Prometheon Pharma LLC
Purdue University
Quadmedicine
Quoin Pharmaceuticals Inc
Radius Health Inc
Raphas Co Ltd
Rescue Biomedical LLC
Resilient Lifescience Inc
Ryah Medtech Inc
Sanofi
Satio Inc
Seelos Therapeutics, Inc.
Serina Therapeutics Inc
Shenox Pharmaceuticals LLC
Sichuan Kelun Pharmaceutical Co Ltd
Sinsin Pharmaceutical Co Ltd
Skinject Inc
Sorrento Therapeutics Inc (Inactive)
Sparsha Pharma International Pvt Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stanford University
Starton Therapeutics Inc
Suzhou Reveda Medical Co Ltd
Swansea University
Syntropharma Ltd (Inactive)
Taho Pharmaceuticals Ltd
Teikoku Pharma USA Inc
tesa Labtec GmbH
Tetra Pharm Technologies ApS
Teva Pharmaceutical Industries Ltd
Texas Tech University
The Sheikh Zayed Institute for Pediatric Surgical Innovation
TheraJect Inc
Therapeutic Systems Research Laboratories Inc
TheraSolve NV (Inactive)
Theratech, Inc.
Theris Medical Inc
Titan Pharmaceuticals Inc
Transcu Group Limited (Inactive)
Transdermal Delivery Solutions Corp
Transdermal Specialties Inc
Transform SciTech Pvt Ltd
TransPharma Medical Ltd (Inactive)
Transport Pharmaceuticals Inc
University of Connecticut Health Center
University of Helsinki
University of Hong Kong
University of Illinois at Chicago
University of Iowa
University of Kentucky
University of North Carolina
University of Pittsburgh
University of South Florida
University of the Philippines Manila
University of the Witwatersrand
University of Tokyo
University of Toronto
University of Washington
Vaxess Technologies Inc
Vaxxas Pty Ltd
Veradermics Inc
Viatris Inc
ViiV Healthcare UK Ltd
Virpax Pharmaceuticals Inc
Vyteris, Inc. (Inactive)
Wellfully Ltd
Xel Pharmaceuticals Inc (Inactive)
Zambon Italia Srl
Z-Cube Srl
Zosano Pharma Corp
Zylo Therapeutics LLC
Zynerba Pharmaceuticals Inc

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Transdermal Drug Delivery Overview

3 Products under Development

3.1 Transdermal Drug Delivery – Pipeline Products by Stage of Development

3.2 Transdermal Drug Delivery – Pipeline Products by Segment

3.3 Transdermal Drug Delivery – Pipeline Products by Territory

3.4 Transdermal Drug Delivery – Pipeline Products by Regulatory Path

3.5 Transdermal Drug Delivery – Pipeline Products by Estimated Approval Date

3.6 Transdermal Drug Delivery – Ongoing Clinical Trials

4 Transdermal Drug Delivery – Pipeline Products under Development by Companies

4.1 Transdermal Drug Delivery Companies – Pipeline Products by Stage of Development

4.2 Transdermal Drug Delivery – Pipeline Products by Stage of Development

5 Transdermal Drug Delivery Companies and Product Overview

5.1 3P Biotechnologies Inc Company Overview

5.1.1 3P Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 AbbVie Inc Company Overview

5.2.1 AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 Abionic SA Company Overview

5.3.1 Abionic SA Pipeline Products & Ongoing Clinical Trials Overview

5.4 Actuated Medical Inc Company Overview

5.4.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 AcusMu Medtech Co Ltd Company Overview

5.5.1 AcusMu Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.6 Adynxx Inc Company Overview

5.6.1 Adynxx Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 Aequus Pharmaceuticals Inc Company Overview

5.7.1 Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.8 AerMedX Ltd Company Overview

5.8.1 AerMedX Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.9 Agile Therapeutics Inc Company Overview

5.9.1 Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.10 American Chemical Society Company Overview

5.10.1 American Chemical Society Pipeline Products & Ongoing Clinical Trials Overview

5.11 AMW GmbH Company Overview

5.11.1 AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.12 Amzell BV Company Overview

5.12.1 Amzell BV Pipeline Products & Ongoing Clinical Trials Overview

5.13 Anodyne Nanotech Inc Company Overview

5.13.1 Anodyne Nanotech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.14 Apogee Technology Inc Company Overview

5.14.1 Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

5.15 Asahi Kasei Pharma Corp Company Overview

5.15.1 Asahi Kasei Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview

5.16 ASCIL Biopharm Company Overview

5.16.1 ASCIL Biopharm Pipeline Products & Ongoing Clinical Trials Overview

5.17 Avecho Biotechnology Ltd Company Overview

5.17.1 Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.18 Avro Life Sciences Company Overview

5.18.1 Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview

5.19 Better Life Pharmaceuticals Inc Company Overview

5.19.1 Better Life Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.20 BioNxt Solutions Inc Company Overview

5.20.1 BioNxt Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

5.21 Boryung Pharmaceutical Co Ltd Company Overview

5.21.1 Boryung Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.22 Burke Pharmaceuticals LLC Company Overview

5.22.1 Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview

5.23 Candesant Biomedical Inc Company Overview

5.23.1 Candesant Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.24 Carnegie Mellon University Company Overview

5.24.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview

5.25 Cassava Sciences Inc Company Overview

5.25.1 Cassava Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.26 CB Scientific Inc Company Overview

5.26.1 CB Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview

5.27 Celltrion Inc Company Overview

5.27.1 Celltrion Inc Pipeline Products & Ongoing Clinical Trials Overview

5.28 Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview

5.28.1 Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.29 Changchun University of Chinese Medicine Company Overview

5.29.1 Changchun University of Chinese Medicine Pipeline Products & Ongoing Clinical Trials Overview

5.30 Chrono Therapeutics Inc Company Overview

5.30.1 Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.31 Cipla Ltd Company Overview

5.31.1 Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.32 Clexio Biosciences Ltd Company Overview

5.32.1 Clexio Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.33 Corium LLC Company Overview

5.33.1 Corium LLC Pipeline Products & Ongoing Clinical Trials Overview

5.34 CS Medica A/S Company Overview

5.34.1 CS Medica A/S Pipeline Products & Ongoing Clinical Trials Overview

5.35 Daewon Pharmaceutical Co Ltd Company Overview

5.35.1 Daewon Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.36 Daewoong Pharmaceutical Co Ltd Company Overview

5.36.1 Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.37 DBV Technologies SA Company Overview

5.37.1 DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview

5.38 DD Therapeutics LLC (Inactive) Company Overview

5.38.1 DD Therapeutics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.39 Delpor Inc Company Overview

5.39.1 Delpor Inc Pipeline Products & Ongoing Clinical Trials Overview

5.40 Dermisonics Inc Company Overview

5.40.1 Dermisonics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.41 Dharma Therapeutics, Inc. (Inactive) Company Overview

5.41.1 Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.42 Dong-A ST Co Ltd Company Overview

5.42.1 Dong-A ST Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.43 Drexel University Company Overview

5.43.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview

5.44 DURECT Corp Company Overview

5.44.1 DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview

5.45 Echo Therapeutics Inc (Inactive) Company Overview

5.45.1 Echo Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.46 Emplicure AB Company Overview

5.46.1 Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview

5.47 Endo International Plc Company Overview

5.47.1 Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview

5.48 Endomimetics LLC Company Overview

5.48.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.49 Extend Biosciences Inc Company Overview

5.49.1 Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.50 Fe3 Medical Inc Company Overview

5.50.1 Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.51 Feplen Health Research Pvt Ltd Company Overview

5.51.1 Feplen Health Research Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.52 Futura Medical Plc Company Overview

5.52.1 Futura Medical Plc Pipeline Products & Ongoing Clinical Trials Overview

5.53 Georgetown University Company Overview

5.53.1 Georgetown University Pipeline Products & Ongoing Clinical Trials Overview

5.54 Georgia Institute of Technology Company Overview

5.54.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

5.55 Georgia State University Company Overview

5.55.1 Georgia State University Pipeline Products & Ongoing Clinical Trials Overview

5.56 Gerresheimer AG Company Overview

5.56.1 Gerresheimer AG Pipeline Products & Ongoing Clinical Trials Overview

5.57 GlobeStar Therapeutics Corp Company Overview

5.57.1 GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview

5.58 Gylden Pharma Limited Company Overview

5.58.1 Gylden Pharma Limited Pipeline Products & Ongoing Clinical Trials Overview

5.59 Henley Ion LLC Company Overview

5.59.1 Henley Ion LLC Pipeline Products & Ongoing Clinical Trials Overview

5.60 Hera Health Solutions Company Overview

5.60.1 Hera Health Solutions Pipeline Products & Ongoing Clinical Trials Overview

5.61 Hisamitsu Pharmaceutical Co Inc Company Overview

5.61.1 Hisamitsu Pharmaceutical Co Inc Pipeline Products & Ongoing Clinical Trials Overview

5.62 I.M. Sechenov First Moscow State Medical University Company Overview

5.62.1 I.M. Sechenov First Moscow State Medical University Pipeline Products & Ongoing Clinical Trials Overview

5.63 Icure Pharmaceutical Inc Company Overview

5.63.1 Icure Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.64 ImmunoMatrix LLC Company Overview

5.64.1 ImmunoMatrix LLC Pipeline Products & Ongoing Clinical Trials Overview

5.65 ImmuPatch Company Overview

5.65.1 ImmuPatch Pipeline Products & Ongoing Clinical Trials Overview

5.66 Indian Institute of Science Company Overview

5.66.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview

5.67 Indian Institute of Technology Bombay Company Overview

5.67.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview

5.68 Indian Institute of Technology Hyderabad Company Overview

5.68.1 Indian Institute of Technology Hyderabad Pipeline Products & Ongoing Clinical Trials Overview

5.69 Indian Institute of Technology, Kanpur Company Overview

5.69.1 Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview

5.70 InMed Pharmaceuticals Inc Company Overview

5.70.1 InMed Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.71 Institute of Materials Research & Engineering Company Overview

5.71.1 Institute of Materials Research & Engineering Pipeline Products & Ongoing Clinical Trials Overview

5.72 InteguRx Therapeutics LLC Company Overview

5.72.1 InteguRx Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.73 Intercell AG (Inactive) Company Overview

5.73.1 Intercell AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.74 Interstitial NS Company Overview

5.74.1 Interstitial NS Pipeline Products & Ongoing Clinical Trials Overview

5.75 Isis Biopolymer Inc (Inactive) Company Overview

5.75.1 Isis Biopolymer Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.76 James J. Peters VA Medical Center Company Overview

5.76.1 James J. Peters VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.77 Janisys Company Overview

5.77.1 Janisys Pipeline Products & Ongoing Clinical Trials Overview

5.78 Jiaxing Xinwen Biotechnology Co Ltd Company Overview

5.78.1 Jiaxing Xinwen Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.79 Karolinska Institute Company Overview

5.79.1 Karolinska Institute Pipeline Products & Ongoing Clinical Trials Overview

5.80 Kindeva Drug Delivery LP Company Overview

5.80.1 Kindeva Drug Delivery LP Pipeline Products & Ongoing Clinical Trials Overview

5.81 KTH Royal Institute of Technology Company Overview

5.81.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

5.82 Leo Pharma AS Company Overview

5.82.1 Leo Pharma AS Pipeline Products & Ongoing Clinical Trials Overview

5.83 Libero Pharma Ltd Company Overview

5.83.1 Libero Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.84 Livzon Pharmaceutical Group Inc Company Overview

5.84.1 Livzon Pharmaceutical Group Inc Pipeline Products & Ongoing Clinical Trials Overview

5.85 LTS Lohmann Therapie-Systeme AG Company Overview

5.85.1 LTS Lohmann Therapie-Systeme AG Pipeline Products & Ongoing Clinical Trials Overview

5.86 Luye Pharma Group Ltd Company Overview

5.86.1 Luye Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.87 Massachusetts Institute of Technology Company Overview

5.87.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

5.88 Mayne Pharma Group Ltd Company Overview

5.88.1 Mayne Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.89 Medherant Ltd Company Overview

5.89.1 Medherant Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.90 MEDRx Co Ltd Company Overview

5.90.1 MEDRx Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.91 Microdermics Inc Company Overview

5.91.1 Microdermics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.92 Micron Biomedical Inc Company Overview

5.92.1 Micron Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.93 Micropoint Technologies Pte Ltd Company Overview

5.93.1 Micropoint Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.94 Mineed Technology Co Ltd Company Overview

5.94.1 Mineed Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.95 Mycrodose Therapeutics Inc Company Overview

5.95.1 Mycrodose Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.96 MyLife Technologies Company Overview

5.96.1 MyLife Technologies Pipeline Products & Ongoing Clinical Trials Overview

5.97 Nanyang Technological University Company Overview

5.97.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview

5.98 National Dental Centre Singapore Company Overview

5.98.1 National Dental Centre Singapore Pipeline Products & Ongoing Clinical Trials Overview

5.99 National University of Singapore Company Overview

5.99.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview

5.100 nCap Medical LLC Company Overview

5.100.1 nCap Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.101 Nemaura Pharma Ltd Company Overview

5.101.1 Nemaura Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.102 NeuroDerm Ltd Company Overview

5.102.1 NeuroDerm Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.103 Nexgel Inc Company Overview

5.103.1 Nexgel Inc Pipeline Products & Ongoing Clinical Trials Overview

5.104 Nitto Denko Corp Company Overview

5.104.1 Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview

5.105 North Carolina State University Company Overview

5.105.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview

5.106 Nova Graphene Ballistics Inc Company Overview

5.106.1 Nova Graphene Ballistics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.107 Noven Pharmaceuticals Inc Company Overview

5.107.1 Noven Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.108 NutriBand Inc Company Overview

5.108.1 NutriBand Inc Pipeline Products & Ongoing Clinical Trials Overview

5.109 Nuvo Pharmaceuticals Inc (Inactive) Company Overview

5.109.1 Nuvo Pharmaceuticals Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.110 Ohio State University Company Overview

5.110.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview

5.111 Old Dominion University Company Overview

5.111.1 Old Dominion University Pipeline Products & Ongoing Clinical Trials Overview

5.112 Osprey Medical Inc Company Overview

5.112.1 Osprey Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.113 Pantec Biosolutions AG Company Overview

5.113.1 Pantec Biosolutions AG Pipeline Products & Ongoing Clinical Trials Overview

5.114 PassPort Technologies Inc Company Overview

5.114.1 PassPort Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.115 PATH Company Overview

5.115.1 PATH Pipeline Products & Ongoing Clinical Trials Overview

5.116 Pebble Inc Company Overview

5.116.1 Pebble Inc Pipeline Products & Ongoing Clinical Trials Overview

5.117 PharmaTher Holdings Ltd Company Overview

5.117.1 PharmaTher Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.118 Privo Technologies Inc Company Overview

5.118.1 Privo Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.119 Prometheon Pharma LLC Company Overview

5.119.1 Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview

5.120 Purdue University Company Overview

5.120.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview

5.121 Quadmedicine Company Overview

5.121.1 Quadmedicine Pipeline Products & Ongoing Clinical Trials Overview

5.122 Quoin Pharmaceuticals Inc Company Overview

5.122.1 Quoin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.123 Radius Health Inc Company Overview

5.123.1 Radius Health Inc Pipeline Products & Ongoing Clinical Trials Overview

5.124 Raphas Co Ltd Company Overview

5.124.1 Raphas Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.125 Rescue Biomedical LLC Company Overview

5.125.1 Rescue Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.126 Resilient Lifescience Inc Company Overview

5.126.1 Resilient Lifescience Inc Pipeline Products & Ongoing Clinical Trials Overview

5.127 Ryah Medtech Inc Company Overview

5.127.1 Ryah Medtech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.128 Sanofi Company Overview

5.128.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview

5.129 Satio Inc Company Overview

5.129.1 Satio Inc Pipeline Products & Ongoing Clinical Trials Overview

5.130 Seelos Therapeutics, Inc. Company Overview

5.130.1 Seelos Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.131 Serina Therapeutics Inc Company Overview

5.131.1 Serina Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.132 Shenox Pharmaceuticals LLC Company Overview

5.132.1 Shenox Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview

5.133 Sichuan Kelun Pharmaceutical Co Ltd Company Overview

5.133.1 Sichuan Kelun Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.134 Sinsin Pharmaceutical Co Ltd Company Overview

5.134.1 Sinsin Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.135 Skinject Inc Company Overview

5.135.1 Skinject Inc Pipeline Products & Ongoing Clinical Trials Overview

5.136 Sorrento Therapeutics Inc (Inactive) Company Overview

5.136.1 Sorrento Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.137 Sparsha Pharma International Pvt Ltd Company Overview

5.137.1 Sparsha Pharma International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.138 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

5.138.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

5.139 Stanford University Company Overview

5.139.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview

5.140 Starton Therapeutics Inc Company Overview

5.140.1 Starton Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.141 Suzhou Reveda Medical Co Ltd Company Overview

5.141.1 Suzhou Reveda Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.142 Swansea University Company Overview

5.142.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview

5.143 Syntropharma Ltd (Inactive) Company Overview

5.143.1 Syntropharma Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.144 Taho Pharmaceuticals Ltd Company Overview

5.144.1 Taho Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.145 Teikoku Pharma USA Inc Company Overview

5.145.1 Teikoku Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview

5.146 tesa Labtec GmbH Company Overview

5.146.1 tesa Labtec GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.147 Tetra Pharm Technologies ApS Company Overview

5.147.1 Tetra Pharm Technologies ApS Pipeline Products & Ongoing Clinical Trials Overview

5.148 Teva Pharmaceutical Industries Ltd Company Overview

5.148.1 Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.149 Texas Tech University Company Overview

5.149.1 Texas Tech University Pipeline Products & Ongoing Clinical Trials Overview

5.150 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview

5.150.1 The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview

5.151 TheraJect Inc Company Overview

5.151.1 TheraJect Inc Pipeline Products & Ongoing Clinical Trials Overview

5.152 Therapeutic Systems Research Laboratories Inc Company Overview

5.152.1 Therapeutic Systems Research Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

5.153 TheraSolve NV (Inactive) Company Overview

5.153.1 TheraSolve NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.154 Theratech, Inc. Company Overview

5.154.1 Theratech, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.155 Theris Medical Inc Company Overview

5.155.1 Theris Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.156 Titan Pharmaceuticals Inc Company Overview

5.156.1 Titan Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.157 Transcu Group Limited (Inactive) Company Overview

5.157.1 Transcu Group Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.158 Transdermal Delivery Solutions Corp Company Overview

5.158.1 Transdermal Delivery Solutions Corp Pipeline Products & Ongoing Clinical Trials Overview

5.159 Transdermal Specialties Inc Company Overview

5.159.1 Transdermal Specialties Inc Pipeline Products & Ongoing Clinical Trials Overview

5.160 Transform SciTech Pvt Ltd Company Overview

5.160.1 Transform SciTech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.161 TransPharma Medical Ltd (Inactive) Company Overview

5.161.1 TransPharma Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.162 Transport Pharmaceuticals Inc Company Overview

5.162.1 Transport Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.163 University of Connecticut Health Center Company Overview

5.163.1 University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview

5.164 University of Helsinki Company Overview

5.164.1 University of Helsinki Pipeline Products & Ongoing Clinical Trials Overview

5.165 University of Hong Kong Company Overview

5.165.1 University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview

5.166 University of Illinois at Chicago Company Overview

5.166.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview

5.167 University of Iowa Company Overview

5.167.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview

5.168 University of Kentucky Company Overview

5.168.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview

5.169 University of North Carolina Company Overview

5.169.1 University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview

5.170 University of Pittsburgh Company Overview

5.170.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

5.171 University of South Florida Company Overview

5.171.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

5.172 University of the Philippines Manila Company Overview

5.172.1 University of the Philippines Manila Pipeline Products & Ongoing Clinical Trials Overview

5.173 University of the Witwatersrand Company Overview

5.173.1 University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview

5.174 University of Tokyo Company Overview

5.174.1 University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview

5.175 University of Toronto Company Overview

5.175.1 University of Toronto Pipeline Products & Ongoing Clinical Trials Overview

5.176 University of Washington Company Overview

5.176.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview

5.177 Vaxess Technologies Inc Company Overview

5.177.1 Vaxess Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.178 Vaxxas Pty Ltd Company Overview

5.178.1 Vaxxas Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.179 Veradermics Inc Company Overview

5.179.1 Veradermics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.180 Viatris Inc Company Overview

5.180.1 Viatris Inc Pipeline Products & Ongoing Clinical Trials Overview

5.181 ViiV Healthcare UK Ltd Company Overview

5.181.1 ViiV Healthcare UK Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.182 Virpax Pharmaceuticals Inc Company Overview

5.182.1 Virpax Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.183 Vyteris, Inc. (Inactive) Company Overview

5.183.1 Vyteris, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.184 Wellfully Ltd Company Overview

5.184.1 Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.185 Xel Pharmaceuticals Inc (Inactive) Company Overview

5.185.1 Xel Pharmaceuticals Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.186 Zambon Italia Srl Company Overview

5.186.1 Zambon Italia Srl Pipeline Products & Ongoing Clinical Trials Overview

5.187 Z-Cube Srl Company Overview

5.187.1 Z-Cube Srl Pipeline Products & Ongoing Clinical Trials Overview

5.188 Zosano Pharma Corp Company Overview

5.188.1 Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview

5.189 Zylo Therapeutics LLC Company Overview

5.189.1 Zylo Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.190 Zynerba Pharmaceuticals Inc Company Overview

5.190.1 Zynerba Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Transdermal Drug Delivery- Recent Developments

6.1 Oct 16, 2024: Lilly Confirms Date and Conference Call for Third-Quarter 2024 Financial Results Announcement

6.2 Oct 09, 2024: Eli Lilly Appoints Chief AI Officer

6.3 Oct 09, 2024: Daewoong Pharmaceutical Unveils ‘Innovative Drug Delivery Technologies’ in Milan From World’s First Microneedle Therapy to Once-a-Month Obesity Treatment

6.4 Sep 30, 2024: Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results on November 6, 2024

6.5 Sep 10, 2024: “Dermatologic Surgery” Journal Publishes Special Issue on Neuromodulators

6.6 Sep 10, 2024: KalVista Names Brian Piekos as Chief Financial Officer

6.7 Sep 09, 2024: Eli Lilly Promotes Lucas Montarce to CFO

6.8 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.9 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.10 Aug 14, 2024: Solasia Pharma Reports Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2024

6.11 Aug 14, 2024: Solasia Pharma Announces Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2024

6.12 Aug 09, 2024: Transdermal Drug-Delivery Firm TDS Pharm Confident of Growth Ahead of IPO

6.13 Aug 01, 2024: 3M Names Anurag Maheshwari as Executive Vice President and Chief Financial Officer

6.14 Jul 26, 2024: 3M Delivers Strong Second-Quarter Results; Company Updates Full-Year 2024 Earnings Guidance

6.15 Jul 14, 2024: GSK Moves to New HQ in Return to Central London

6.16 Jul 10, 2024: 3M Announces Departure of Chief Financial Officer

6.17 Jul 02, 2024: Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024

6.18 Jun 27, 2024: KalVista Initiates KONFIDENT-KID Trial for On-demand Treatment of Hereditary Angioedema Attacks with Sebetralstat in Children Aged 2 to 11

6.19 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.20 Jun 04, 2024: Kindeva Drug Delivery Expands Loughborough, UK, Facilities at Charnwood Campus to Support Growth of Green Propellant Commercialization

6.21 May 29, 2024: Karolinska Institutet : Microneedle Patch Can Detect Skin Cancer Early

6.22 May 21, 2024: KalVista Pharmaceuticals to Present at Upcoming Investor Conferences

6.23 Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin

6.24 Apr 26, 2024: Nitto Denko Announces Consolidated Financial Statements for the Year Ended March 31, 2024

6.25 Apr 16, 2024: Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results

6.26 Apr 03, 2024: KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference

6.27 Apr 02, 2024: Camurus Notice of Annual General Meeting 2024

6.28 Mar 26, 2024: Quality That Sticks Around: Henkel Facilities Receive Excipact Certificate as Suppliers of Pharmaceutical Excipients

6.29 Mar 13, 2024: 3M Names New CEO Amid PFAS Battles, Health Spinoff

6.30 Mar 12, 2024: 3M Announces New Leadership Appointments

6.31 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.32 Mar 06, 2024: Japanese Pharma with North Carolina Offices to Lay Off 400

6.33 Mar 06, 2024: KalVista Pharmaceuticals to Participate in the Leerink Partners 2024 Global Biopharma Conference

6.34 Mar 05, 2024: Sumitomo Pharma to Cut 400 Jobs at U.S. Subsidiary

6.35 Mar 04, 2024: Revance Therapeutics Announces Proposed $100M Share Offering

6.36 Jan 31, 2024: Kindeva Drug Delivery Launches New Analytical Services Global Business Unit

6.37 Jan 31, 2024: Kindeva Drug Delivery Launches New Analytical Services Global Business Unit

6.38 Jan 17, 2024: Starton Therapeutics Announces STARTICLES Filing

6.39 Jan 16, 2024: 3M Picks Former NuVasive CEO as President of Medical Solutions

6.40 Jan 11, 2024: Raphas Makes Strategic Equity Investment in SML Biopharm

6.41 Jan 02, 2024: Starton Therapeutics Announces the Launch of STARSILON a Novel Proprietary Transdermal PATCH Delivery Platform

6.42 Dec 20, 2023: KalVista Pharmaceuticals Announces Publication of First Oral Factor XIIa Data in Frontiers in Pharmacology

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Transdermal Drug Delivery – Pipeline Products by Stage of Development

Transdermal Drug Delivery – Pipeline Products by Segment

Transdermal Drug Delivery – Pipeline Products by Territory

Transdermal Drug Delivery – Pipeline Products by Regulatory Path

Transdermal Drug Delivery – Pipeline Products by Estimated Approval Date

Transdermal Drug Delivery – Ongoing Clinical Trials

Transdermal Drug Delivery Companies – Pipeline Products by Stage of Development

Transdermal Drug Delivery – Pipeline Products by Stage of Development

3P Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview

PolyC – Product Status

PolyC – Product Description

AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview

Nanotechnology-Based Transdermal Delivery System – Product Status

Nanotechnology-Based Transdermal Delivery System – Product Description

Norethindrone Transdermal Delivery System – Product Status

Norethindrone Transdermal Delivery System – Product Description

Abionic SA Pipeline Products & Ongoing Clinical Trials Overview

COVID-19 DNA Vaccine Microneedle Patch – Product Status

COVID-19 DNA Vaccine Microneedle Patch – Product Description

Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

GentleDispense System – Product Status

GentleDispense System – Product Description

AcusMu Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

AcusMu Microneedle Patch – Periorbital Wrinkles – Product Status

AcusMu Microneedle Patch – Periorbital Wrinkles – Product Description

Vaccine Microneedle Patch – Product Status

Vaccine Microneedle Patch – Product Description

AcusMu Medtech Co Ltd – Ongoing Clinical Trials Overview

AcusMu Microneedle Patch – Periorbital Wrinkles – Assessing the Efficacy and Safety of the AcusMu Microneedle Patch in Treating Periorbital Wrinkles and Skin Diseases

Adynxx Inc Pipeline Products & Ongoing Clinical Trials Overview

Transdermal Postherpetic Neuralgia Pain Patch – Product Status

Transdermal Postherpetic Neuralgia Pain Patch – Product Description

Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

AQS1301 – Product Status

AQS1301 – Product Description

AQS1302 – Product Status

AQS1302 – Product Description

AQS1303 – Product Status

AQS1303 – Product Description

AQS1304 – Product Status

AQS1304 – Product Description

AerMedX Ltd Pipeline Products & Ongoing Clinical Trials Overview

Deposition System – Product Status

Deposition System – Product Description

Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

AG200-ER Patch – Product Status

AG200-ER Patch – Product Description

AG200-SP Patch – Product Status

AG200-SP Patch – Product Description

AG890 Patch – Product Status

AG890 Patch – Product Description

American Chemical Society Pipeline Products & Ongoing Clinical Trials Overview

COVID-19 Microneedle Patch – Product Status

COVID-19 Microneedle Patch – Product Description

AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview

Anastrozole Transdermal Patch – Product Status

Anastrozole Transdermal Patch – Product Description

Amzell BV Pipeline Products & Ongoing Clinical Trials Overview

AMZ001 – Product Status

AMZ001 – Product Description

Anodyne Nanotech Inc Pipeline Products & Ongoing Clinical Trials Overview

Hero Patch – Product Status

Hero Patch – Product Description

Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

PyraDerm – Product Status

PyraDerm – Product Description

Asahi Kasei Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview

Teribone Microneedle Patch System – Product Status

Teribone Microneedle Patch System – Product Description

ASCIL Biopharm Pipeline Products & Ongoing Clinical Trials Overview

Minimally Invasive Transdermal System – Product Status

Minimally Invasive Transdermal System – Product Description

Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview

TPM – Diclofenac Patch – Product Status

TPM – Diclofenac Patch – Product Description

TPM – Lidocaine Patch – Product Status

TPM – Lidocaine Patch – Product Description

TPM – Oxycodone Patch – Product Status

TPM – Oxycodone Patch – Product Description

TPM – Oxymorphone Patch – Product Status

TPM – Oxymorphone Patch – Product Description

Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview

OmniDerm – Product Status

OmniDerm – Product Description

Remdesivir Transdermal Patch – Product Status

Remdesivir Transdermal Patch – Product Description

Better Life Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Thrudermic Patch – Product Status

Thrudermic Patch – Product Description

BioNxt Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

Rotigotine Transdermal Patch – Product Status

Rotigotine Transdermal Patch – Product Description

BioNxt Solutions Inc – Ongoing Clinical Trials Overview

Rotigotine Transdermal Patch – A Human Clinical Pilot Study to Assess the Relative Bioavailability, Skin Adhesion and Skin Tolerance of Rotigotine Transdermal Patch

Boryung Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Donepezil Patch – Product Status

Donepezil Patch – Product Description

Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview

BLU402 Hydrogel Patch Wart Kit – Product Status

BLU402 Hydrogel Patch Wart Kit – Product Description

Drug Delivery Patch – Product Status

Drug Delivery Patch – Product Description

Candesant Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

Bi-Layer Patch – Facial Hyperhidrosis – Product Status

Bi-Layer Patch – Facial Hyperhidrosis – Product Description

Bi-Layer Patch – Palmar Hyperhidrosis – Product Status

Bi-Layer Patch – Palmar Hyperhidrosis – Product Description

Bi-Layer Patch – Plantar Hyperhidrosis – Product Status

Bi-Layer Patch – Plantar Hyperhidrosis – Product Description

Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview

Bioresorbable Drug Delivery Patch – Product Status

Bioresorbable Drug Delivery Patch – Product Description

Cassava Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview

FENROCK – Product Status

FENROCK – Product Description

CB Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview

Pain-Patch – Product Status

Pain-Patch – Product Description

Celltrion Inc Pipeline Products & Ongoing Clinical Trials Overview

Donepezil Patch – Product Status

Donepezil Patch – Product Description

Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Topical Diclofenac Patch – Product Status

Topical Diclofenac Patch – Product Description

Changchun University of Chinese Medicine Pipeline Products & Ongoing Clinical Trials Overview

Warm Palace Analgesic Point Sticker – Product Status

Warm Palace Analgesic Point Sticker – Product Description

Changchun University of Chinese Medicine – Ongoing Clinical Trials Overview

Warm Palace Analgesic Point Sticker – Research and Development of Warm Palace Analgesic Point Stickers Based on the Modern Technology of Traditional Chinese Medicine: Study Protocol for A Randomized Controlled Trial

Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Biologically-Timed Drug Delivery Device – Product Status

Biologically-Timed Drug Delivery Device – Product Description

Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview

CPN-101 – Product Status

CPN-101 – Product Description

Clexio Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview

CLE-200 – Product Status

CLE-200 – Product Description

Corium LLC Pipeline Products & Ongoing Clinical Trials Overview

Corplex Memantine Transdermal System – Product Status

Corplex Memantine Transdermal System – Product Description

Corplex Ropinirole Transdermal System – Product Status

Corplex Ropinirole Transdermal System – Product Description

MicroCor hPTH(1-34) Transdermal System – Product Status

MicroCor hPTH(1-34) Transdermal System – Product Description

MicroCor Zolmitriptan Transdermal System – Product Status

MicroCor Zolmitriptan Transdermal System – Product Description

CS Medica A/S Pipeline Products & Ongoing Clinical Trials Overview

CANNASEN Pain Patch – Product Status

CANNASEN Pain Patch – Product Description

Daewon Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

DW-1022 – Product Status

DW-1022 – Product Description

Daewon Pharmaceutical Co Ltd – Ongoing Clinical Trials Overview

DW-1022 – A Study To Assess the Effects of the DW-1022 for Obesity Treatment

Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

CLOPAM (Closed-Packed Aeroperssured Microneedle) Patch – Product Status

CLOPAM (Closed-Packed Aeroperssured Microneedle) Patch – Product Description

Donepezil Patch – Product Status

Donepezil Patch – Product Description

DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview

Viaskin Milk (2-17 Years) – Product Status

Viaskin Milk (2-17 Years) – Product Description

Viaskin Milk (4-17 Years) – Product Status

Viaskin Milk (4-17 Years) – Product Description

Viaskin Peanut (1-3 Years) – Product Status

Viaskin Peanut (1-3 Years) – Product Description

Viaskin Peanut (4-11 Years) – Product Status

Viaskin Peanut (4-11 Years) – Product Description

Viaskin Peanut – Adolescents and Adults – Product Status

Viaskin Peanut – Adolescents and Adults – Product Description

Viaskin rPT – Product Status

Viaskin rPT – Product Description

Vikasin Egg – Product Status

Vikasin Egg – Product Description

DBV Technologies SA – Ongoing Clinical Trials Overview

Viaskin Peanut (4-11 Years) – A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous Immunotherapy with DBV712 250 µg in 4-7-year-old Children with Peanut Allergy (VITESSE)

DD Therapeutics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Transdermal Delivery System – Product Status

Transdermal Delivery System – Product Description

Delpor Inc Pipeline Products & Ongoing Clinical Trials Overview

Risperidone Subcutaneous Implant – Product Status

Risperidone Subcutaneous Implant – Product Description

Tizanidine Implant – Product Status

Tizanidine Implant – Product Description

Dermisonics Inc Pipeline Products & Ongoing Clinical Trials Overview

U-Strip – Product Status

U-Strip – Product Description

Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Iontophoretic Drug Delivery Patch – Product Status

Iontophoretic Drug Delivery Patch – Product Description

Dong-A ST Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Donepezil Transdermal Patch – Product Status

Donepezil Transdermal Patch – Product Description

Drexel University Pipeline Products & Ongoing Clinical Trials Overview

Ultrasonically Assisted Transcutaneous Drug Delivery Device – Product Status

Ultrasonically Assisted Transcutaneous Drug Delivery Device – Product Description

DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview

Eladur – Product Status

Eladur – Product Description

TRANSDUR – Sufentanil – Product Status

TRANSDUR – Sufentanil – Product Description

Echo Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Prelude SkinPrep System – Product Status

Prelude SkinPrep System – Product Description

Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview

Micro-Needle Patch – Product Status

Micro-Needle Patch – Product Description

Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview

Rivastigmine Patch – Product Status

Rivastigmine Patch – Product Description

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

AVF Gel – Product Status

AVF Gel – Product Description

Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

Non-Invasive Needle-Free Skin Patch – Product Status

Non-Invasive Needle-Free Skin Patch – Product Description

Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Fe3 Patch – Product Status

Fe3 Patch – Product Description

Feplen Health Research Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Noninvasive Transdermal Electrical Patch – Product Status

Noninvasive Transdermal Electrical Patch – Product Description

Futura Medical Plc Pipeline Products & Ongoing Clinical Trials Overview

MED3000 – Rx – Product Status

MED3000 – Rx – Product Description

Futura Medical Plc – Ongoing Clinical Trials Overview

MED3000 – Rx – MED3000 Topical Gel for On-Demand Treatment of Post-Radical Prostatectomy Erectile Dysfunction

Georgetown University Pipeline Products & Ongoing Clinical Trials Overview

Passive Transdermal Drug Delivery Patch – Parkinson’s Disease – Product Status

Passive Transdermal Drug Delivery Patch – Parkinson’s Disease – Product Description

Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

Micron – Scale Arcing Device – Product Status

Micron – Scale Arcing Device – Product Description

Microneedle Patch – Measles – Product Status

Microneedle Patch – Measles – Product Description

Microneedle Patch – Polio – Product Status

Microneedle Patch – Polio – Product Description

Microneedle Patch – Rubella – Product Status

Microneedle Patch – Rubella – Product Description

Georgia State University Pipeline Products & Ongoing Clinical Trials Overview

Microneedle Patch – Flu – Product Status

Microneedle Patch – Flu – Product Description

Gerresheimer AG Pipeline Products & Ongoing Clinical Trials Overview

Integrated Subcutaneous Cancer Therapy System – Product Status

Integrated Subcutaneous Cancer Therapy System – Product Description

GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview

Transdermal PGE-1 Patch – Product Status

Transdermal PGE-1 Patch – Product Description

Gylden Pharma Limited Pipeline Products & Ongoing Clinical Trials Overview

COVID-19 Vaccine Skin Patch – Product Status

COVID-19 Vaccine Skin Patch – Product Description

Henley Ion LLC Pipeline Products & Ongoing Clinical Trials Overview

Anesthesia Delivery Dental Device – Product Status

Anesthesia Delivery Dental Device – Product Description

Hera Health Solutions Pipeline Products & Ongoing Clinical Trials Overview

Biodegradable Subcutaneous Buprenorphine Releasing Implant – Product Status

Biodegradable Subcutaneous Buprenorphine Releasing Implant – Product Description

Hisamitsu Pharmaceutical Co Inc Pipeline Products & Ongoing Clinical Trials Overview

HP-1030 Adhesive Skin Patch – Product Status

HP-1030 Adhesive Skin Patch – Product Description

HP-5000 Topical Patch – Product Status

HP-5000 Topical Patch – Product Description

HTU-520 Patch – Product Status

HTU-520 Patch – Product Description

I.M. Sechenov First Moscow State Medical University Pipeline Products & Ongoing Clinical Trials Overview

Anti-Cancer Patch – Product Status

Anti-Cancer Patch – Product Description

Icure Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview

Exenatide Patch – Product Status

Exenatide Patch – Product Description

Fentanyl Pain Relief Patch – Product Status

Fentanyl Pain Relief Patch – Product Description

Fomoterol Patch – Product Status

Fomoterol Patch – Product Description

Melatonin Patch – Product Status

Melatonin Patch – Product Description

Physostigmine Patch – Product Status

Physostigmine Patch – Product Description

Pramipexole Parkinson’s Patch – Product Status

Pramipexole Parkinson’s Patch – Product Description

Rotigotine Patch – Product Status

Rotigotine Patch – Product Description

Varenicline Patch – Product Status

Varenicline Patch – Product Description

ImmunoMatrix LLC Pipeline Products & Ongoing Clinical Trials Overview

Dermal Skin Patch Delivery System – Product Status

Dermal Skin Patch Delivery System – Product Description

ImmuPatch Pipeline Products & Ongoing Clinical Trials Overview

Coated ImmuPatch – Product Status

Coated ImmuPatch – Product Description

Dissolvable ImmuPatch – Product Status

Dissolvable ImmuPatch – Product Description

Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview

Drug Delivery Patch – Product Status

Drug Delivery Patch – Product Description

Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview

Poly (n-Vinyl Caprolactam) Transdermal Drug Delivery System – Product Status

Poly (n-Vinyl Caprolactam) Transdermal Drug Delivery System – Product Description

Indian Institute of Technology Hyderabad Pipeline Products & Ongoing Clinical Trials Overview

Transdermal Mucoadhesive Patch – Product Status

Transdermal Mucoadhesive Patch – Product Description

Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview

Transdermal Gel – Melanoma Therapy – Product Status

Transdermal Gel – Melanoma Therapy – Product Description

InMed Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

INM-755 – Drug Delivery Device – Product Status

INM-755 – Drug Delivery Device – Product Description

MiDROPS INM-088 Drug Delivery Device – Product Status

MiDROPS INM-088 Drug Delivery Device – Product Description

Institute of Materials Research & Engineering Pipeline Products & Ongoing Clinical Trials Overview

Skin Breaching Device – Product Status

Skin Breaching Device – Product Description

InteguRx Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview

Apixaban Transdermal Patch – Product Status

Apixaban Transdermal Patch – Product Description

Ondansetron Transdermal Patch – Product Status

Ondansetron Transdermal Patch – Product Description

Intercell AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Travelers Diarrhea Vaccine Patch – Product Status

Travelers Diarrhea Vaccine Patch – Product Description

Interstitial NS Pipeline Products & Ongoing Clinical Trials Overview

NanoMAP – Product Status

NanoMAP – Product Description

Isis Biopolymer Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Gentle Touch – Product Status

Gentle Touch – Product Description

IsisIQ CLI – Product Status

IsisIQ CLI – Product Description

James J. Peters VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Iontophoresis Patch – Product Status

Iontophoresis Patch – Product Description

Janisys Pipeline Products & Ongoing Clinical Trials Overview

Janisys Drug Delivery System – Product Status

Janisys Drug Delivery System – Product Description

Jiaxing Xinwen Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Transdermal Drug Delivery System – Neurology – Product Status

Transdermal Drug Delivery System – Neurology – Product Description

Transdermal Drug Delivery System – Pain – Product Status

Transdermal Drug Delivery System – Pain – Product Description

Karolinska Institute Pipeline Products & Ongoing Clinical Trials Overview

Microneedle Patch – MRSA – Product Status

Microneedle Patch – MRSA – Product Description

Kindeva Drug Delivery LP Pipeline Products & Ongoing Clinical Trials Overview

Hollow Microstructured Transdermal System – Product Status

Hollow Microstructured Transdermal System – Product Description

Solid Microneedles Transdermal System – Product Status

Solid Microneedles Transdermal System – Product Description

KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

Microneedle Skin Patch – Product Status

Microneedle Skin Patch – Product Description

Leo Pharma AS Pipeline Products & Ongoing Clinical Trials Overview

Microneedle Patch – Psoriasis – Product Status

Microneedle Patch – Psoriasis – Product Description

Libero Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview

Naltrexone Transdermal Patch – Product Status

Naltrexone Transdermal Patch – Product Description

Livzon Pharmaceutical Group Inc Pipeline Products & Ongoing Clinical Trials Overview

Asenapine TTS – Product Status

Asenapine TTS – Product Description

LTS Lohmann Therapie-Systeme AG Pipeline Products & Ongoing Clinical Trials Overview

Dissolvable Microneedle Array Patch – Rabies Vaccine – Product Status

Dissolvable Microneedle Array Patch – Rabies Vaccine – Product Description

Intradermal Microneedle Patch – Product Status

Intradermal Microneedle Patch – Product Description

Micro Array Patch – Contraception – Product Status

Micro Array Patch – Contraception – Product Description

Smart Patch – Product Status

Smart Patch – Product Description

Luye Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview

Apleek – Product Status

Apleek – Product Description

Rivalif – Product Status

Rivalif – Product Description

Rivastigmine Twice Weekly Transdermal Patch – Product Status

Rivastigmine Twice Weekly Transdermal Patch – Product Description

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

Manuka Honey Microneedle – Product Status

Manuka Honey Microneedle – Product Description

Microneedle Patch – Melanoma – Product Status

Microneedle Patch – Melanoma – Product Description

Wearable Ultrasound Patch – Product Status

Wearable Ultrasound Patch – Product Description

Mayne Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview

Motion Sickness Transdermal Delivery System Patch – Product Status

Motion Sickness Transdermal Delivery System Patch – Product Description

Medherant Ltd Pipeline Products & Ongoing Clinical Trials Overview

Diclofenac TEPI Patch – Product Status

Diclofenac TEPI Patch – Product Description

Donepezil TEPI Patch – Product Status

Donepezil TEPI Patch – Product Description

Dronabinol TEPI Patch – Product Status

Dronabinol TEPI Patch – Product Description

Ibuprofen TEPI Patch – Product Status

Ibuprofen TEPI Patch – Product Description

Lidocaine TEPI Patch – Product Status

Lidocaine TEPI Patch – Product Description

Memantine TEPI Patch – Product Status

Memantine TEPI Patch – Product Description

Methyl Salicylate TEPI Patch – Product Status

Methyl Salicylate TEPI Patch – Product Description

Testosterone TEPI Patch – Product Status

Testosterone TEPI Patch – Product Description

Medherant Ltd – Ongoing Clinical Trials Overview

Testosterone TEPI Patch – A Clinical Trial Application For Phase I Study Of Medherant’s Testosterone Patch For Post-Menopausal Women

Testosterone TEPI Patch – A Confirmatory Pharmacokinetic Study to Evaluate the Efficacy TEPI Patch in Post-menopausal Women

MEDRx Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

ALTO-101 Patch – Product Status

ALTO-101 Patch – Product Description

Aricept – Product Status

Aricept – Product Description

Etoreat – Product Status

Etoreat – Product Description

KENZAN Microneedle Array – Product Status

KENZAN Microneedle Array – Product Description

Lydolyte – Product Status

Lydolyte – Product Description

Microneedle Array Patch Vaccine – Product Status

Microneedle Array Patch Vaccine – Product Description

MRX – 4TZT Patch – Product Status

MRX – 4TZT Patch – Product Description

MRX-1OXT Patch – Product Status

MRX-1OXT Patch – Product Description

MRX-6LDT Tape – Product Status

MRX-6LDT Tape – Product Description

MRX-7LAT Lidocaine Patch – Product Status

MRX-7LAT Lidocaine Patch – Product Description

MRX-7MLL – Product Status

MRX-7MLL – Product Description

MRX-9FLT Patch – Product Status

MRX-9FLT Patch – Product Description

MEDRx Co Ltd – Ongoing Clinical Trials Overview

ALTO-101 Patch – Study of ALTO-101 in Patients With Schizophrenia

Microdermics Inc Pipeline Products & Ongoing Clinical Trials Overview

Microneedle Drug Delivery System – Product Status

Microneedle Drug Delivery System – Product Description

Micron Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

Microneedle Patch – Contraception – Product Status

Microneedle Patch – Contraception – Product Description

Microneedle Patch – Virus Infection – Product Status

Microneedle Patch – Virus Infection – Product Description

Micropoint Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

Drug-Coated Micropoint Patch – Product Status

Drug-Coated Micropoint Patch – Product Description

Mineed Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Detachable and Dissolvable Microneedle Patch – Product Status

Detachable and Dissolvable Microneedle Patch – Product Description

Mycrodose Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Psilocin Transdermal Drug Delivery System – Product Status

Psilocin Transdermal Drug Delivery System – Product Description

Transdermal Drug Delivery System – LSD – Product Status

Transdermal Drug Delivery System – LSD – Product Description

MyLife Technologies Pipeline Products & Ongoing Clinical Trials Overview

Ceramic Vaccine Patch – Product Status

Ceramic Vaccine Patch – Product Description

Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview

Skin Pressure Device – Product Status

Skin Pressure Device – Product Description

National Dental Centre Singapore Pipeline Products & Ongoing Clinical Trials Overview

MN Patch – Product Status

MN Patch – Product Description

National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview

Microneedle Granule – Drug Delivery – Product Status

Microneedle Granule – Drug Delivery – Product Description

Microneedle Skin Patch – Product Status

Microneedle Skin Patch – Product Description

nCap Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

NEUROCUPLE Patch – Product Status

NEUROCUPLE Patch – Product Description

nCap Medical LLC – Ongoing Clinical Trials Overview

NEUROCUPLE Patch – Enhancing Pain Management for Knee Replacement Patients through an Innovative Non-invasive and Opioid-sparing Device (NEUROCUPLE)

Nemaura Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview

Memspatch – Product Status

Memspatch – Product Description

Microneedle Drug Delivery Device – Product Status

Microneedle Drug Delivery Device – Product Description

Micropatch – Product Status

Micropatch – Product Description

Mycrolator – Product Status

Mycrolator – Product Description

Transdermal Patch – Alzheimer’s Disease – Product Status

Transdermal Patch – Alzheimer’s Disease – Product Description

Transdermal Patch – Buprenorphine – Product Status

Transdermal Patch – Buprenorphine – Product Description

Transdermal Patch – Diclofenac – Product Status

Transdermal Patch – Diclofenac – Product Description

Transdermal Patch – Hypertension – Product Status

Transdermal Patch – Hypertension – Product Description

Transdermal Patch – Nicotine – Product Status

Transdermal Patch – Nicotine – Product Description

Transdermal Patch – Parkinson’s Disease – Product Status

Transdermal Patch – Parkinson’s Disease – Product Description

Transdermal Patch – Rivastigmine – Product Status

Transdermal Patch – Rivastigmine – Product Description

NeuroDerm Ltd Pipeline Products & Ongoing Clinical Trials Overview

ND0601 Dermal Patch – Product Status

ND0601 Dermal Patch – Product Description

ND0611 Dermal Patch – Product Status

ND0611 Dermal Patch – Product Description

Nexgel Inc Pipeline Products & Ongoing Clinical Trials Overview

Diclofenac Hydrogel Patch – Product Status

Diclofenac Hydrogel Patch – Product Description

Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview

Transdermal Enoxaparin Sodium Patch – Product Status

Transdermal Enoxaparin Sodium Patch – Product Description

Transdermal Fentanyl Citrate Patch – Product Status

Transdermal Fentanyl Citrate Patch – Product Description

Transdermal Protein Patch – Product Status

Transdermal Protein Patch – Product Description

North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview

Antibody Delivery Microneedle Patch – Product Status

Antibody Delivery Microneedle Patch – Product Description

Intraconazole Microneedle Patch – Product Status

Intraconazole Microneedle Patch – Product Description

Skin Patch – Melanoma – Product Status

Skin Patch – Melanoma – Product Description

Nova Graphene Ballistics Inc Pipeline Products & Ongoing Clinical Trials Overview

Anti-Addiction Patch – Product Status

Anti-Addiction Patch – Product Description

Noven Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Lidocaine Topical Patch – Product Status

Lidocaine Topical Patch – Product Description

NutriBand Inc Pipeline Products & Ongoing Clinical Trials Overview

4P Apomorphine Transdermal Patch – Product Status

4P Apomorphine Transdermal Patch – Product Description

4P Chronic Pain Transdermal Patch – Product Status

4P Chronic Pain Transdermal Patch – Product Description

4P Clonidine Transdermal Patch – Product Status

4P Clonidine Transdermal Patch – Product Description

4P Diabetes Transdermal Patch – Product Status

4P Diabetes Transdermal Patch – Product Description

4P Lidocaine Transdermal Patch – Product Status

4P Lidocaine Transdermal Patch – Product Description

4P Migraine Transdermal Patch – Product Status

4P Migraine Transdermal Patch – Product Description

4P Scopolamine Transdermal Patch – Product Status

4P Scopolamine Transdermal Patch – Product Description

Aversa – Product Status

Aversa – Product Description

Aversa Buprenorphine Patch – Product Status

Aversa Buprenorphine Patch – Product Description

AVERSA Fentanyl Abuse Deterrent Patch – Product Status

AVERSA Fentanyl Abuse Deterrent Patch – Product Description

Aversa Methylphenidate Patch – Product Status

Aversa Methylphenidate Patch – Product Description

Ciprofloxacin Transdermal Patch – Product Status

Ciprofloxacin Transdermal Patch – Product Description

TD00A1 – Transdermal Drug Delivery System – Product Status

TD00A1 – Transdermal Drug Delivery System – Product Description

TD00G1 – Transdermal Drug Delivery System – Product Status

TD00G1 – Transdermal Drug Delivery System – Product Description

TD0CD1/TD0CD2 – Transdermal Drug Delivery System – Product Status

TD0CD1/TD0CD2 – Transdermal Drug Delivery System – Product Description

Figures

Transdermal Drug Delivery – Pipeline Products by Stage of Development

Transdermal Drug Delivery – Pipeline Products by Segment

Transdermal Drug Delivery – Pipeline Products by Territory

Transdermal Drug Delivery – Pipeline Products by Regulatory Path

Transdermal Drug Delivery – Pipeline Products by Estimated Approval Date

Transdermal Drug Delivery – Ongoing Clinical Trials

Frequently asked questions

Transdermal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Transdermal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Transdermal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Transdermal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.